Stocks to Watch on May 14, 2025: Bharti Airtel, Tata Motors, HAL, Cipla, and More in Focus
Check today’s key stocks in focus including Bharti Airtel, Tata Motors, HAL, Cipla, and more. Get earnings updates, stock movements, and investment insights for May 14, 2025.
Stocks to Watch on May 14, 2025: Bharti Airtel, Tata Motors, HAL, Cipla, and More in Focus

As markets open today, several key stocks are expected to be in the spotlight, driven by quarterly earnings announcements, strategic developments, and institutional activity. Here's a roundup of the top stocks to watch:
🔍 Key Stocks in Focus
HAL, Tata Power, Eicher Motors, Jubilant FoodWorks
These companies are scheduled to release their Q4 FY25 results today, making them ones to watch for potential market movements.
📊 Company Highlights
Bharti Airtel
Bharti Airtel posted a sharp 432% year-on-year (YoY) increase in net profit, reaching ₹11,022 crore for Q4. After excluding exceptional items, the adjusted net profit grew 77% YoY to ₹5,223 crore, showing robust underlying performance.
Tata Motors
The auto major reported a 51% YoY drop in consolidated net profit, which came in at ₹8,470 crore for the March 2025 quarter.
Bharti Hexacom
Airtel’s subsidiary, Bharti Hexacom, saw a 79% quarter-on-quarter (QoQ) rise in net profit, reaching ₹468 crore. Revenue from operations climbed 2% QoQ to ₹2,289 crore.
Garden Reach Shipbuilders & Engineers
The Defence PSU reported a 118.9% YoY surge in net profit to ₹244.2 crore in Q4FY25, reflecting strong operational performance.
Bank of India (BoI)
LIC increased its stake in Bank of India to 8.38% as of May 9, signaling continued institutional confidence in the bank.
Tata Steel
Tata Steel has announced a capital expenditure plan of ₹15,000 crore for FY26, with investments spread across its operations in India, the UK, and the Netherlands.
Aditya Birla Capital
The company reported a net profit of ₹654 crore for Q4FY25. Net interest income for the quarter stood at ₹1,800 crore.
Cipla
Cipla CEO Umang Vohra clarified that the recent US government order requiring pharmaceutical companies to lower prescription drug prices within 30 days will not impact Indian generic drug manufacturers, providing clarity for stakeholders.
Metropolis Healthcare
The diagnostics firm reported a 19.4% YoY drop in Q4 net profit to ₹29 crore, compared to ₹36 crore in the same quarter last year.
⚠️ Disclaimer:
This article is for informational purposes only. The views and stock recommendations mentioned are those of individual analysts or brokerage firms. Investors should consult certified financial advisors before making any investment decisions.